Supriya Lifescience Statistics
Total Valuation
Supriya Lifescience has a market cap or net worth of INR 47.89 billion. The enterprise value is 47.20 billion.
Market Cap | 47.89B |
Enterprise Value | 47.20B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | Sep 20, 2024 |
Share Statistics
Supriya Lifescience has 80.48 million shares outstanding. The number of shares has decreased by -0.07% in one year.
Shares Outstanding | 80.48M |
Shares Change (YoY) | -0.07% |
Shares Change (QoQ) | +0.15% |
Owned by Insiders (%) | 68.30% |
Owned by Institutions (%) | 7.77% |
Float | 24.60M |
Valuation Ratios
The trailing PE ratio is 35.42.
PE Ratio | 35.42 |
Forward PE | n/a |
PS Ratio | 8.00 |
PB Ratio | 5.87 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 34.90 |
EV / Sales | 7.88 |
EV / EBITDA | 24.64 |
EV / EBIT | 27.04 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.67 |
Debt / EBITDA | 0.03 |
Debt / FCF | n/a |
Interest Coverage | 107.13 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 14.14% |
Revenue Per Employee | 15.28M |
Profits Per Employee | 3.45M |
Employee Count | 392 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +109.67% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +109.67% |
50-Day Moving Average | 456.63 |
200-Day Moving Average | 368.76 |
Relative Strength Index (RSI) | 72.89 |
Average Volume (20 Days) | 983,610 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Supriya Lifescience had revenue of INR 5.99 billion and earned 1.35 billion in profits. Earnings per share was 16.80.
Revenue | 5.99B |
Gross Profit | 3.76B |
Operating Income | 1.75B |
Pretax Income | 1.83B |
Net Income | 1.35B |
EBITDA | 1.92B |
EBIT | 1.75B |
Earnings Per Share (EPS) | 16.80 |
Balance Sheet
The company has 749.56 million in cash and 54.88 million in debt, giving a net cash position of 694.68 million or 8.63 per share.
Cash & Cash Equivalents | 749.56M |
Total Debt | 54.88M |
Net Cash | 694.68M |
Net Cash Per Share | 8.63 |
Equity (Book Value) | 8.15B |
Book Value Per Share | 101.34 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 62.75%, with operating and profit margins of 29.14% and 22.58%.
Gross Margin | 62.75% |
Operating Margin | 29.14% |
Pretax Margin | 30.52% |
Profit Margin | 22.58% |
EBITDA Margin | 31.98% |
EBIT Margin | 29.14% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 0.13%.
Dividend Per Share | 0.80 |
Dividend Yield | 0.13% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.07% |
Shareholder Yield | 0.20% |
Earnings Yield | 2.82% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |